(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, announced today the pricing of its previously announced private offering of $275 million aggregate ...
Three regional organizations say a methodology change doesn't capture infrastructure being built now, including nearly $1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results